Loading…
← CockpitCompetitor Analysis › 3030.TW Test Research, Inc.Open in the cockpit ↗

Test Research, Inc.3030.TWCompetitor analysis, valuation and peers

Taiwan · TWD·Industrials›Industrial Machinery

Taiwanese maker of automated test equipment (ATE) and in-circuit testers used to inspect PCBs and electronics.

≈ A Taiwanese peer to Teradyne in electronics test equipmentMomentum laggard 13
Mkt cap
$1.46B
US dollars, full cap
Free float
61%
of shares outstanding
$/day
$11.0M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
+24.5 pp
WACC 6.2%
Hurdle
-13 pp
Req g minus delivered
Next earnings
98 days
24 Feb 2027
Close · TWDNT$216.00
1D+1.9%
1W-7.5%
1M-25.4%
3M-26.8%
6M-45.3%
YTD+12.8%
1Y+30.5%
ATR %7.2%
52w lowhigh52.8% off high

What Test Research does

Taiwanese maker of automated test equipment (ATE) and in-circuit testers used to inspect PCBs and electronics.

Sells inspection and test machines to electronics makers when they build or expand production lines, so orders follow factory capital spending, and inspection demand rises as circuit boards become denser. Spare parts and upgrades follow the initial sale.

In one line: A Taiwanese peer to Teradyne in electronics test equipment.

Products and services

  • In-circuit testers
  • Automated test equipment

Customers

  • Electronics contract manufacturers

Where it sits in the supply chain

  • Information Technology hardware
  • Test equipment
  • Automated test equipment, in-circuit…

What could go right

  • Electronics manufacturing test/inspection demand

What could go wrong

  • Electronics capex cyclicality

Moat: narrow (process know-how, IP / patents). Specialized test-equipment engineering know-how qualified across electronics manufacturers.

Headquarters: New Taipei City, Taiwan · Founded: 1986

Named competitors

Test Research at a glance

Size Test Research (3030.TW) is a Taiwan Industrials company (Industrial Machinery) with a market value of $1.46B, the 205th largest of 648 Taiwan companies the cockpit tracks. Shares closed at NT$216.00 on 18 Nov 2026.

Performance Over six months the shares fell 45.3%, against -23.3% for the median peer and -3.4% for the Taiwan market (cap-weighted) — 2nd lowest of 21 in its peer set.

Growth Revenue grew 31.6% over the last twelve months (peer median +11.8%); the operating margin is 36.8% (peer median 12.0%).

Valuation It trades at 4.6× enterprise value to sales against a peer median of 3.2× (9th most expensive of 21).

Price implies For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is -13 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 24.5 points above its cost of capital (6.2% WACC).

Next results Next results expected around 24 Feb 2027 (exchange calendar; dates can move).

Relative performance

608010021 May 202621 Aug 202618 Nov 2026Peer median 773030.TW 56
Six months, rebased to 100: Test Research against the median of its 20 peers (local-currency closes).

Test Research financials

Reported figures in TWD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueNT$10.4BNT$8.47BNT$6.36BNT$4.44BNT$6.71B
Revenue growth—+33%+43%-34%—
Gross profitNT$6.09BNT$4.94BNT$3.78BNT$2.63BNT$3.85B
EBITDANT$4.02BNT$3.19BNT$2.22BNT$1.35BNT$2.29B
Net incomeNT$3.26BNT$2.48BNT$1.84BNT$1.00BNT$1.92B
Free cash flowNT$1.62BNT$1.43BNT$790MNT$1.02BNT$813M
Capital expenditureNT$353MNT$300MNT$389MNT$877MNT$680M
Total debtNT$67.3MNT$68.2MNT$46.7MNT$66.7MNT$62.4M

Quarterly statements and history in the cockpit →

Test Research competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%-20%0%002164HLIO6880591651688139688543688306INRNCROMPTON300185603203LUVEGDWN68802830017100269830139231670025343030.TW6-month return →1-month return →
Up and to the right = strong over both horizons. Test Research is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%5×10×15×002164HLIO6880591651688139688543INRNCROMPTON300185601882603203LUVEGDWN68802830017100269830139231670025343030.TWRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Test Research is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%-20%0%20%40%HLIO1651688139688306INRNCROMPTON300185601882603203GDWN3001710025343030.TWGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Test Research is the large dot.

Test Research competitors and peer comparison

Head to head with its named competitors (3030.TW vs TER vs 2360.TW vs 3563.TW)
CompanyMarket cap6M returnRevenue growthOp. marginEV / SalesReq g
Test Research 3030.TW$1.46B-45%+32%37%4.6×-1.5%
Teradyne TER$36.7B-32%+75%33%7.3×22.6%
Chroma Ate 2360.TW$13.2B-49%+101%39%8.4×15.7%
MACHVISION 3563.TW$977M-39%+17%37%7.7×5.5%

How Test Research compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Test Research against its 20 peers (data as of 18 Nov 2026)
Measure3030.TWPeer medianRank in peer set
1-month return-25.4%-10.2%4th lowest of 21
6-month return-45.3%-23.3%2nd lowest of 21
Distance from 52-week high-52.8%-44.2%6th lowest of 21
Revenue growth (TTM)+31.6%+11.8%3rd highest of 21
Operating margin36.8%12.0%highest of 21
EV / Sales4.6×3.2×9th most expensive of 21
Growth the price implies (Req g, 7 yrs)-1.5%13.0%2nd least demanding of 15
Growth delivered (Del g)+11.3%+9.5%4th highest of 15
Hurdle (Req g minus delivered)-12.8 pp+3.9 pp2nd least demanding of 15
ROIC minus cost of capital+24.5 pp+0.3 pp2nd highest of 21
EV / EBITDA11.8×14.8×3rd cheapest of 7
Net debt / EBITDA-0.2×-0.1×4th least indebted of 7

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Test Research 3030.TWTaiwan$1.46B-45%+32%37%4.6×-1.5%+11.3%
Ningbo Donly 002164.SZChina$1.46B+31%+5%5%6.5×n/an/a
Helios Technologies HLIOUnited States$1.47B-43%+12%13%1.9×9.8%+9.9%
Zhuzhou Huarui Precision Cutting Tools 688059.SSChina$1.47B-32%+23%36%8.6×n/an/a
Precision Tsugami (China) 1651.HKHong Kong$1.47B-42%+25%30%1.5×-17.7%+9.8%
Qingdao Haier Biomedical 688139.SSChina$1.45B-11%+12%9%3.4×18.8%+10.8%
Jiangxi Guoke Defence 688543.SSChina$1.45B-19%+2%16%7.2×n/an/a
Ningbo PIA Automation 688306.SSChina$1.45B-23%+7%4%3.6×31.7%+8.7%
Interroll INRN.SWSwitzerland$1.44B-8%+2%13%1.9×2.0%-0.6%
Crompton Greaves Consumer Electricals CROMPTON.NSIndia$1.43B-29%+12%8%1.5×20.0%+11.0%
Tongyu Heavy Industry 300185.SZChina$1.43B-24%+6%4%2.0×5.0%+3.1%
Ningbo Haitian Precision Machinery 601882.SSChina$1.50B-21%+19%11%2.3×12.2%+15.6%
Quick Intelligent Equipment 603203.SSChina$1.51B-40%+20%21%7.3×28.0%+15.2%
LU-VE LUVE.MIItaly$1.51B-6%+12%11%2.2×13.9%+8.6%
Goodwin GDWN.LUnited Kingdom$1.41B+3%+2%13%15.5×47.6%-12.1%
Beijing Worldia Diamond Tools 688028.SSChina$1.40B-48%+22%16%10.6×n/an/a
Tofflon Science and Technology 300171.SZChina$1.40B-3%-2%6%1.1×4.7%+14.0%
Harbin Boshi Automation 002698.SZChina$1.53B-31%-2%18%3.1×3.9%+9.1%
Guangdong Huicheng Vacuum Technology 301392.SZChina$1.53B-32%+48%7%17.4×n/an/a
Ta Liang Technology 3167.TWTaiwan$1.54B-15%+122%28%5.2×n/an/a
Xizi Clean Energy Equipment Manufacturing 002534.SZChina$1.55B-26%-2%3%1.7×23.3%+3.1%

Questions

Who are Test Research's main competitors?
Named competitors: Teradyne (TER), Chroma ATE (2360.TW), MACHVISION (3563.TW). The cockpit's measured peer set (industry) also includes Ningbo Donly (002164.SZ), Helios Technologies (HLIO), Zhuzhou Huarui Precision Cutting Tools (688059.SS), Precision Tsugami (China) (1651.HK), Qingdao Haier Biomedical (688139.SS), Jiangxi Guoke Defence (688543.SS).
Is Test Research expensive compared with its peers?
On ev / sales it trades at 4.6× against a peer median of 3.2×, 9th most expensive of 21 in its peer set. For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is -13 pp: the price already allows for a slowdown.
How has Test Research stock performed?
Over six months to 18 Nov 2026 the shares returned -45.3% against -23.3% for the median peer; over one year +30.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.